Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 264 articles:
HTML format



Single Articles


    November 2020
  1. WANG L, Wang W
    Safety and efficacy of anaplastic lymphoma kinase tyrosine kinase inhibitors in nonsmall cell lung cancer (Review).
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7851.
    PubMed     Abstract available


  2. HASE H, Aoki M, Matsumoto K, Nakai S, et al
    Cancer typeSLCO1B3 promotes epithelialmesenchymal transition resulting in the tumour progression of nonsmall cell lung cancer.
    Oncol Rep. 2020 Nov 6. doi: 10.3892/or.2020.7839.
    PubMed     Abstract available


  3. REN T, Tang YJ, Wang MF, Wang HS, et al
    Triptolide induces apoptosis through the calcium/calmodulindependent protein kinase kinasebeta/AMPactivated protein kinase signaling pathway in nonsmall cell lung cancer cells.
    Oncol Rep. 2020;44:2288-2296.
    PubMed     Abstract available


    October 2020
  4. CUI XY, Park SH, Park WH
    Auranofin inhibits the proliferation of lung cancer cells via necrosis and caspasedependent apoptosis.
    Oncol Rep. 2020 Oct 21. doi: 10.3892/or.2020.7818.
    PubMed     Abstract available


  5. PARK WH
    Propyl gallate reduces the growth of lung cancer cells through caspasedependent apoptosis and G1 phase arrest of the cell cycle.
    Oncol Rep. 2020 Oct 20. doi: 10.3892/or.2020.7815.
    PubMed     Abstract available


    September 2020
  6. ZHAO X, Li M, Dai X, Yang Y, et al
    Downregulation of exosomal miR1273a increases cisplatin resistance of nonsmall cell lung cancer by upregulating the expression of syndecan binding protein.
    Oncol Rep. 2020 Sep 4. doi: 10.3892/or.2020.7753.
    PubMed     Abstract available


  7. WANG X, Zhang G, Cheng Z, Dai L, et al
    Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR98 in lung cancer cells.
    Oncol Rep. 2020;44:1025-1036.
    PubMed     Abstract available


  8. ZHAO Y, Ye X, Chen R, Gao Q, et al
    Sirtuin 7 promotes nonsmall cell lung cancer progression by facilitating G1/S phase and epithelialmesenchymal transition and activating AKT and ERK1/2 signaling.
    Oncol Rep. 2020;44:959-972.
    PubMed     Abstract available


  9. SUN L, Yuan W, Wen G, Yu B, et al
    Parthenolide inhibits human lung cancer cell growth by modulating the IGF1R/PI3K/Akt signaling pathway.
    Oncol Rep. 2020;44:1184-1193.
    PubMed     Abstract available


  10. LI W, Li C, Ma L, Jin F, et al
    Resveratrol inhibits viability and induces apoptosis in the smallcell lung cancer H446 cell line via the PI3K/Akt/cMyc pathway.
    Oncol Rep. 2020 Sep 1. doi: 10.3892/or.2020.7747.
    PubMed     Abstract available


    August 2020
  11. LI D, Wang L, Feng J, Shen YW, et al
    RP11284F21.9 promotes lung carcinoma proliferation and invasion via the regulation of miR6273p/CCAR1.
    Oncol Rep. 2020 Aug 12. doi: 10.3892/or.2020.7732.
    PubMed     Abstract available


  12. GUAN Y, Yang J, Liu X, Chu L, et al
    Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of nonsmallcell lung cancer by sponging microRNA5093p and competitively upregulating HDAC9 expression.
    Oncol Rep. 2020 Aug 7. doi: 10.3892/or.2020.7719.
    PubMed     Abstract available


  13. LIU X, Huang S, Guan Y, Zhang Q, et al
    Long noncoding RNA OSER1AS1 promotes the malignant properties of nonsmall cell lung cancer by sponging microRNA4333p and thereby increasing Smad2 expression.
    Oncol Rep. 2020;44:599-610.
    PubMed     Abstract available


    July 2020
  14. GAO F, Li M, Zhou L, Liu W, et al
    Xanthohumol targets the ERK1/2Fra1 signaling axis to reduce cyclin D1 expression and inhibit nonsmall cell lung cancer.
    Oncol Rep. 2020 Jul 20. doi: 10.3892/or.2020.7697.
    PubMed     Abstract available


  15. WANG L, Wu L, Pang J
    Long noncoding RNA PSMA3AS1 functions as a microRNA4093p sponge to promote the progression of nonsmall cell lung carcinoma by targeting spindlin 1.
    Oncol Rep. 2020 Jul 15. doi: 10.3892/or.2020.7693.
    PubMed     Abstract available


    June 2020
  16. CHEN J, Lin Q, Ni T, Zhao J, et al
    NLK interacts with 1433zeta to restore the expression of Ecadherin.
    Oncol Rep. 2020;43:1845-1852.
    PubMed     Abstract available


  17. HUANG T, Ren K, Ding G, Yang L, et al
    miR10a increases the cisplatin resistance of lung adenocarcinoma circulating tumor cells via targeting PIK3CA in the PI3K/Akt pathway.
    Oncol Rep. 2020;43:1906-1914.
    PubMed     Abstract available


    May 2020
  18. WU X, Li X, Xu G
    Propofol suppresses the progression of nonsmall cell lung cancer via downregulation of the miR215p/MAPK10 axis.
    Oncol Rep. 2020 May 21. doi: 10.3892/or.2020.7619.
    PubMed     Abstract available


    April 2020
  19. EGUCHI R, Wakabayashi I
    HDGF enhances VEGFdependent angiogenesis and FGF2 is a VEGFindependent angiogenic factor in nonsmall cell lung cancer.
    Oncol Rep. 2020 Apr 9. doi: 10.3892/or.2020.7580.
    PubMed     Abstract available


  20. DU W, Sun L, Liu T, Zhu J, et al
    The miR6253p/AXL axis induces nonT790M acquired resistance to EGFRTKI via activation of the TGFbeta/Smad pathway and EMT in EGFRmutant nonsmall cell lung cancer.
    Oncol Rep. 2020 Apr 8. doi: 10.3892/or.2020.7579.
    PubMed     Abstract available


  21. FAN S, Liao Y, Qiu W, Huang Q, et al
    Estrogen promotes the metastasis of nonsmall cell lung cancer via estrogen receptor beta by upregulation of Tolllike receptor 4 and activation of the myd88/NFkappaB/MMP2 pathway.
    Oncol Rep. 2020 Apr 2. doi: 10.3892/or.2020.7574.
    PubMed     Abstract available


  22. YANG MQ, Bai LL, Lei L, Zheng YW, et al
    DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Oncol Rep. 2020;43:1338-1348.
    PubMed     Abstract available


    March 2020
  23. LV L, Zhang W, Li T, Jiang L, et al
    Hispidulin exhibits potent anticancer activity in vitro and in vivo through activating ER stress in nonsmallcell lung cancer cells.
    Oncol Rep. 2020 Mar 30. doi: 10.3892/or.2020.7568.
    PubMed     Abstract available


  24. WANG J, Zhang ZQ, Li FQ, Chen JN, et al
    Triptolide interrupts rRNA synthesis and induces the RPL23MDM2p53 pathway to repress lung cancer cells.
    Oncol Rep. 2020 Mar 30. doi: 10.3892/or.2020.7569.
    PubMed     Abstract available


  25. WEI M, Li J, Qiu J, Yan Y, et al
    Costunolide induces apoptosis and inhibits migration and invasion in H1299 lung cancer cells.
    Oncol Rep. 2020 Mar 26. doi: 10.3892/or.2020.7566.
    PubMed     Abstract available


  26. HU J, Shang Y, Shi X, Zhang S, et al
    Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in nonsmall cell lung cancer.
    Oncol Rep. 2020 Mar 23. doi: 10.3892/or.2020.7559.
    PubMed     Abstract available


  27. NENKOV M, Ma Y, Haase D, Zhou Z, et al
    Growth inhibitory role of the p53 activator SCH 529074 in nonsmall cell lung cancer cells expressing mutant p53.
    Oncol Rep. 2020 Mar 17. doi: 10.3892/or.2020.7546.
    PubMed     Abstract available


  28. LI F, Cui H, Jin X, Gong X, et al
    Triptolide inhibits epithelialmesenchymal transition and induces apoptosis in gefitinibresistant lung cancer cells.
    Oncol Rep. 2020 Mar 10. doi: 10.3892/or.2020.7542.
    PubMed     Abstract available


  29. CHEN L, Ren P, Zhang Y, Gong B, et al
    Long noncoding RNA GAS5 increases the radiosensitivity of A549 cells through interaction with the miR21/PTEN/Akt axis.
    Oncol Rep. 2020;43:897-907.
    PubMed     Abstract available


    February 2020
  30. CAO F, Wang Z, Feng Y, Zhu H, et al
    lncRNA TPTEP1 competitively sponges miR3285p to inhibit the proliferation of nonsmall cell lung cancer cells.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7522.
    PubMed     Abstract available


  31. LI J, Cui J, Li Z, Fu X, et al
    ORP8 induces apoptosis by releasing cytochrome c from mitochondria in nonsmall cell lung cancer.
    Oncol Rep. 2020 Feb 24. doi: 10.3892/or.2020.7517.
    PubMed     Abstract available


  32. ZHAO L, Wang L, Wang Y, Ma P, et al
    Long noncoding RNA CCAT1 enhances human nonsmall cell lung cancer growth through downregulation of microRNA218.
    Oncol Rep. 2020 Feb 12. doi: 10.3892/or.2020.7500.
    PubMed     Abstract available


  33. LI Y, Yin Y, Ma J, Sun Y, et al
    Combination of AAVmediated NUPR1 knockdown and trifluoperazine induces premature senescence in human lung adenocarcinoma A549 cells in nude mice.
    Oncol Rep. 2020;43:681-688.
    PubMed     Abstract available


  34. CAO PP, Chen WJ, Pang HL, Shen WW, et al
    Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Oncol Rep. 2020;43:662-670.
    PubMed     Abstract available


  35. HU F, Li C, Zheng X, Zhang H, et al
    Lung adenocarcinoma resistance to therapy with EGFRtyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG.
    Oncol Rep. 2020;43:727-735.
    PubMed     Abstract available


  36. WANG H, Kanmangne D, Li R, Qian Z, et al
    miR30a3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2.
    Oncol Rep. 2020;43:646-654.
    PubMed     Abstract available


    January 2020
  37. LI Y, Ma C, Qian M, Wen Z, et al
    [Retracted] Downregulation of NOB1 suppresses the proliferation and tumor growth of nonsmall cell lung cancer in vitro and in vivo.
    Oncol Rep. 2020 Jan 29. doi: 10.3892/or.2020.7483.
    PubMed     Abstract available


  38. LI J, Li X, Zhang C, Zhang C, et al
    A signature of tumor immune microenvironment genes associated with the prognosis of nonsmall cell lung cancer.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7464.
    PubMed     Abstract available


  39. MIERZEJEWSKA J, Szczygiel A, Anger-Gora N, Rossowska J, et al
    DeOacylated lipooligosaccharide of E. coli B reduces the number of metastatic foci via downregulation of myeloid cell activity.
    Oncol Rep. 2020;43:270-281.
    PubMed     Abstract available


    December 2019
  40. XIONG J, Xing S, Dong Z, Niu L, et al
    STK31 regulates the proliferation and cell cycle of lung cancer cells via the Wnt/betacatenin pathway and feedback regulation by cmyc.
    Oncol Rep. 2019 Dec 19. doi: 10.3892/or.2019.7441.
    PubMed     Abstract available


  41. HU Z, Zhao P, Xu H
    Hyperoside exhibits anticancer activity in nonsmall cell lung cancer cells with T790M mutations by upregulating FoxO1 via CCAT1.
    Oncol Rep. 2019 Dec 18. doi: 10.3892/or.2019.7440.
    PubMed     Abstract available


  42. TANG X, Li Y, Liu L, Guo R, et al
    Sirtuin 3 induces apoptosis and necroptosis by regulating mutant p53 expression in smallcell lung cancer.
    Oncol Rep. 2019 Dec 17. doi: 10.3892/or.2019.7439.
    PubMed     Abstract available


  43. KIM DS, Lee WK, Park JY
    Association of FOSB exon 4 unmethylation with poor prognosis in patients with latestage nonsmall cell lung cancer.
    Oncol Rep. 2019 Dec 13. doi: 10.3892/or.2019.7431.
    PubMed     Abstract available


  44. HUANG W, Wu Y, Cheng D, He Z, et al
    Mechanism of epithelialmesenchymal transition inhibited by miR203 in nonsmall cell lung cancer.
    Oncol Rep. 2019 Dec 13. doi: 10.3892/or.2019.7433.
    PubMed     Abstract available


  45. ZHAO C, Zheng S, Yan Z, Deng Z, et al
    CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Oncol Rep. 2019 Dec 11. doi: 10.3892/or.2019.7426.
    PubMed     Abstract available


    November 2019
  46. ZHANG J, Li D, Zhang Y, Ding Z, et al
    Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for nonsmall cell lung cancer.
    Oncol Rep. 2019 Nov 13. doi: 10.3892/or.2019.7407.
    PubMed     Abstract available


  47. CHANG WC, Kim HK, Shin BK
    Clinicopathological features and diagnostic methods of ALK fusionpositive nonsmall cell lung cancer in Korea.
    Oncol Rep. 2019 Nov 4. doi: 10.3892/or.2019.7399.
    PubMed     Abstract available


  48. ZHANG L, Tao X, Fu Q, Ge C, et al
    Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways.
    Oncol Rep. 2019;42:1843-1855.
    PubMed     Abstract available


    October 2019
  49. WANG XW, Guo QQ, Wei Y, Ren KM, et al
    Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in nonsmall cell lung cancer.
    Oncol Rep. 2019 Oct 17. doi: 10.3892/or.2019.7378.
    PubMed     Abstract available


  50. ZHENG H, Zhang Y, Zhan Y, Liu S, et al
    Expression of DR5 and cFLIP proteins as novel prognostic biomarkers for nonsmall cell lung cancer patients treated with surgical resection and chemotherapy.
    Oncol Rep. 2019 Oct 4. doi: 10.3892/or.2019.7355.
    PubMed     Abstract available


  51. LI Z, Wang Y, Wu L, Dong Y, et al
    Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkinmediated mitophagy.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7345.
    PubMed     Abstract available


    September 2019
  52. NAN Y
    Lung carcinoma therapy using epidermal growth factor receptortargeted lipid polymeric nanoparticles coloaded with cisplatin and doxorubicin.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7323.
    PubMed     Abstract available


  53. WANG J, Hu ZG, Li D, Xu JX, et al
    Gene expression and prognosis of insulinlike growth factorbinding protein family members in nonsmall cell lung cancer.
    Oncol Rep. 2019 Sep 16. doi: 10.3892/or.2019.7314.
    PubMed     Abstract available


  54. WEI W, Zhao X, Zhu J, Zhang L, et al
    lncRNAu50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Oncol Rep. 2019 Sep 5. doi: 10.3892/or.2019.7302.
    PubMed     Abstract available


  55. ZHANG L, Zhu G, Wang X, Liao X, et al
    Genomewide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
    Oncol Rep. 2019;42:1017-1034.
    PubMed     Abstract available


    July 2019
  56. TIAN Y, Yu M, Sun L, Liu L, et al
    Long noncoding RNA00887 reduces the invasion and metastasis of nonsmall cell lung cancer by causing the degradation of miRNAs.
    Oncol Rep. 2019 Jul 11. doi: 10.3892/or.2019.7228.
    PubMed     Abstract available


  57. SHI C, Xu L, Tang Z, Zhang W, et al
    Knockdown of Nemolike kinase promotes metastasis in nonsmallcell lung cancer.
    Oncol Rep. 2019 Jul 9. doi: 10.3892/or.2019.7226.
    PubMed     Abstract available


  58. LIU Y, Bian T, Feng J, Qian L, et al
    CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.
    Oncol Rep. 2019;42:67-78.
    PubMed     Abstract available


    June 2019
  59. HSU PC, Tian B, Yang YL, Wang YC, et al
    Cucurbitacin E inhibits the Yesassociated protein signaling pathway and suppresses brain metastasis of human nonsmall cell lung cancer in a murine model.
    Oncol Rep. 2019 Jun 20. doi: 10.3892/or.2019.7207.
    PubMed     Abstract available


  60. YIN J, Hu W, Pan L, Fu W, et al
    let7 and miR17 promote selfrenewal and drive gefitinib resistance in nonsmall cell lung cancer.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7197.
    PubMed     Abstract available


  61. CHANG CY, Chang SL, Leu JD, Chang YC, et al
    Comparison of cofilin1 and Twist1 protein expression in human nonsmall cell lung cancer tissues.
    Oncol Rep. 2019 Jun 10. doi: 10.3892/or.2019.7193.
    PubMed     Abstract available


  62. OKITA R, Maeda A, Shimizu K, Nojima Y, et al
    Effect of platinumbased chemotherapy on the expression of natural killer group 2 member D ligands, programmed cell death1 ligand 1 and HLA class I in nonsmall cell lung cancer.
    Oncol Rep. 2019 Jun 3. doi: 10.3892/or.2019.7185.
    PubMed     Abstract available


  63. CAO JX
    miR888 regulates cancer progression by targeting multiple targets in lung adenocarcinoma.
    Oncol Rep. 2019;41:3367-3376.
    PubMed     Abstract available


  64. HAN YG, Yun M, Choi M, Lee SG, et al
    TRAIP regulates Histone H2B monoubiquitination in DNA damage response pathways.
    Oncol Rep. 2019;41:3305-3312.
    PubMed     Abstract available


  65. SONG Z, Yin Y, Hao S, Wei J, et al
    JSK induces G2/M phase cell cycle arrest and apoptosis in A549 and H460 cells via the p53/p21WAF1/CIP1 and p27KIP1 pathways.
    Oncol Rep. 2019;41:3475-3487.
    PubMed     Abstract available


    May 2019
  66. LIU Q, Huo Y, Zheng H, Zhao J, et al
    Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of nonsmall cell lung cancer cells via the HMGB1/RAGE axis and the NFkappaB/STAT3 pathway.
    Oncol Rep. 2019 May 30. doi: 10.3892/or.2019.7176.
    PubMed     Abstract available


  67. XIA Y, Hu C, Lian L, Hui K, et al
    miR497 suppresses malignant phenotype in nonsmall cell lung cancer via targeting KDR.
    Oncol Rep. 2019 May 16. doi: 10.3892/or.2019.7163.
    PubMed     Abstract available


  68. GRZEGRZOLKA J, Gomulkiewicz A, Olbromski M, Glatzel-Plucinska N, et al
    Expression of tesmin (MTL5) in nonsmall cell lung cancer: A preliminary study.
    Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7145.
    PubMed     Abstract available


  69. LU G, Cao L, Zhu C, Xie H, et al
    Improving lung cancer treatment: Hyaluronic acidmodified and glutathioneresponsive amphiphilic TPGSdoxorubicin prodrugentrapped nanoparticles.
    Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7139.
    PubMed     Abstract available


  70. OTA K, Okuma T, Lorenzo A, Yokota A, et al
    Fingolimod sensitizes EGFR wildtype nonsmall cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest.
    Oncol Rep. 2019 May 2. doi: 10.3892/or.2019.7140.
    PubMed     Abstract available


  71. CHEN W, Xin B, Pang H, Han L, et al
    Downregulation of estrogen receptor beta inhibits lung adenocarcinoma cell growth.
    Oncol Rep. 2019;41:2967-2974.
    PubMed     Abstract available


  72. LI Y, Zhao C, Liu J, Lu Z, et al
    CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
    Oncol Rep. 2019;41:2679-2688.
    PubMed     Abstract available


    April 2019
  73. XU C, Wu P, Gao J, Zhang L, et al
    Heptadecanoic acid inhibits cell proliferation in PC9 nonsmallcell lung cancer cells with acquired gefitinib resistance.
    Oncol Rep. 2019 Apr 18. doi: 10.3892/or.2019.7130.
    PubMed     Abstract available


  74. MU X, Li H, Zhou L, Xu W, et al
    TRIM52 regulates the proliferation and invasiveness of lung cancer cells via the Wnt/betacatenin pathway.
    Oncol Rep. 2019 Apr 11. doi: 10.3892/or.2019.7110.
    PubMed     Abstract available


  75. DUAN L, Pang HL, Chen WJ, Shen WW, et al
    The role of GDF15 in bone metastasis of lung adenocarcinoma cells.
    Oncol Rep. 2019;41:2379-2388.
    PubMed     Abstract available


  76. HUANG WT, He RQ, Li XJ, Ma J, et al
    miR146a5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.
    Oncol Rep. 2019;41:2226-2240.
    PubMed     Abstract available


    March 2019
  77. YANG Y, Yang CL, Zhao ZJ, Zuo XX, et al
    Microwave hyperthermia enhances the sensitivity of lung cancer cells to gemcitabine through reactive oxygen speciesinduced autophagic death.
    Oncol Rep. 2019 Mar 22. doi: 10.3892/or.2019.7085.
    PubMed     Abstract available


  78. LU J, Gu X, Liu F, Rui Z, et al
    Antitumor effects of hsamiR6613p on nonsmall cell lung cancer in vivo and in vitro.
    Oncol Rep. 2019 Mar 21. doi: 10.3892/or.2019.7084.
    PubMed     Abstract available


  79. WANG S, Niu X, Bao X, Wang Q, et al
    The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
    Oncol Rep. 2019 Mar 20. doi: 10.3892/or.2019.7080.
    PubMed     Abstract available


  80. QIN X, Chen Z
    Metabolic dependence of cyclosporine A on cell proliferation of human nonsmall cell lung cancer A549 cells and its implication in posttransplant malignancy.
    Oncol Rep. 2019 Mar 18. doi: 10.3892/or.2019.7076.
    PubMed     Abstract available


  81. ZHANG L, Zhang T, Deng Z, Sun L, et al
    MicroRNA3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
    Oncol Rep. 2019;41:1669-1677.
    PubMed     Abstract available


  82. DU M, Wang J, Chen H, Wang S, et al
    MicroRNA200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/cMet signaling pathway.
    Oncol Rep. 2019;41:1497-1508.
    PubMed     Abstract available


  83. TENG X, Fan XF, Li Q, Liu S, et al
    XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Oncol Rep. 2019;41:1875-1882.
    PubMed     Abstract available


    February 2019
  84. JIN HO, Hong SE, Kim JY, Kim MR, et al
    Induction of HSP27 and HSP70 by constitutive overexpression of Redd1 confers resistance of lung cancer cells to ionizing radiation.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7036.
    PubMed     Abstract available


  85. WU Y, Xu M, He R, Xu K, et al
    ARHGAP6 regulates the proliferation, migration and invasion of lung cancer cells.
    Oncol Rep. 2019 Feb 25. doi: 10.3892/or.2019.7031.
    PubMed     Abstract available


  86. LIU W, Chen X, He Y, Tian Y, et al
    TNFalpha inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF1alpha/VASP signaling pathway.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7026.
    PubMed     Abstract available


  87. ALCANTARA KMM, Garcia RL
    MicroRNA92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Oncol Rep. 2019 Feb 19. doi: 10.3892/or.2019.7020.
    PubMed     Abstract available


  88. CHEN P, Gu YY, Ma FC, He RQ, et al
    Expression levels and cotargets of miRNA1263p and miRNA1265p in lung adenocarcinoma tissues: Alphan exploration with RTqPCR, microarray and bioinformatic analyses.
    Oncol Rep. 2019;41:939-953.
    PubMed     Abstract available


  89. DUAN Y, Liu T, Li S, Huang M, et al
    CHAF1B promotes proliferation and reduces apoptosis in 95D lung cancer cells and predicts a poor prognosis in nonsmall cell lung cancer.
    Oncol Rep. 2019 Feb 1. doi: 10.3892/or.2019.6994.
    PubMed     Abstract available


  90. ZHANG N, Jiang W
    Long noncoding RNA DANCR promotes HMGA2mediated invasion in lung adenocarcinoma cells.
    Oncol Rep. 2019;41:1083-1090.
    PubMed     Abstract available


  91. YONESAKA K, Kobayashi Y, Hayashi H, Chiba Y, et al
    Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFRmutant Ba/F3 cells.
    Oncol Rep. 2019;41:1059-1066.
    PubMed     Abstract available


  92. ZOU M, Hu X, Xu B, Tong T, et al
    Glutathione Stransferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.
    Oncol Rep. 2019;41:989-998.
    PubMed     Abstract available


    January 2019
  93. FU Q, Huang Y, Ge C, Li Z, et al
    SHIP1 inhibits cell growth, migration, and invasion in nonsmall cell lung cancer through the PI3K/AKT pathway.
    Oncol Rep. 2019 Jan 30. doi: 10.3892/or.2019.6990.
    PubMed     Abstract available


  94. MA HP, Kong WX, Li XY, Li W, et al
    miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
    Oncol Rep. 2019 Jan 24. doi: 10.3892/or.2019.6983.
    PubMed     Abstract available


  95. ZHANG T, Ma L, Wu P, Li W, et al
    Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in nonsmall cell lung cancer A549 cells via the JAK/STAT3 signaling pathway.
    Oncol Rep. 2019 Jan 22. doi: 10.3892/or.2019.6976.
    PubMed     Abstract available


  96. CHEN S, Zhao Y, Shen F, Long D, et al
    Introduction of exogenous wildtype p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factorkappaB in nonsmall cell lung cancer NCIH1299 cells.
    Oncol Rep. 2019 Jan 10. doi: 10.3892/or.2019.6964.
    PubMed     Abstract available


  97. LIU W, Liang Y, Chan Q, Jiang L, et al
    CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway.
    Oncol Rep. 2019 Jan 9. doi: 10.3892/or.2019.6957.
    PubMed     Abstract available


  98. ZHAI Y, Wei R, Sha S, Lin C, et al
    Effect of NELL1 on lung cancer stemlike cell differentiation.
    Oncol Rep. 2019 Jan 3. doi: 10.3892/or.2019.6954.
    PubMed     Abstract available


  99. KOBAYASHI S, Saio M, Fukuda T, Kimura K, et al
    Image analysis of the nuclear characteristics of emerin protein and the correlation with nuclear grooves and intranuclear cytoplasmic inclusions in lung adenocarcinoma.
    Oncol Rep. 2019;41:133-142.
    PubMed     Abstract available


    December 2018
  100. HUANG T, Zhang H, Wang X, Xu L, et al
    Gambogenic acid inhibits the proliferation of smallcell lung cancer cells by arresting the cell cycle and inducing apoptosis.
    Oncol Rep. 2018 Dec 21. doi: 10.3892/or.2018.6950.
    PubMed     Abstract available


  101. JING J, Liu J, Wang Y, Zhang M, et al
    The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6937.
    PubMed     Abstract available


  102. ZURYN A, Krajewski A, Klimaszewska-Wisniewska A, Grzanka A, et al
    Expression of cyclin B1, D1 and K in nonsmall cell lung cancer H1299 cells following treatment with sulforaphane.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6919.
    PubMed     Abstract available


  103. KATAOKA Y, Ohshio Y, Teramoto K, Igarashi T, et al
    Hypoxiainduced galectin3 enhances RhoA function to activate the motility of tumor cells in nonsmall cell lung cancer.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6915.
    PubMed     Abstract available


  104. LIAO W, Liu J, Liu B, Huang X, et al
    JIB04 induces cell apoptosis via activation of the p53/Bcl2/caspase pathway in MHCC97H and HepG2 cells.
    Oncol Rep. 2018;40:3812-3820.
    PubMed     Abstract available


  105. ZHAO CC, Chen J, Niu RF, Liu Y, et al
    Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
    Oncol Rep. 2018;40:3392-3404.
    PubMed     Abstract available


  106. WANG X, Ding Y, Da B, Fei Y, et al
    Identification of potential prognostic long noncoding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma.
    Oncol Rep. 2018;40:3199-3212.
    PubMed     Abstract available


  107. YAO Z, Wan Y, Li B, Zhai C, et al
    Berberine induces mitochondrialmediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCIH2452 cells.
    Oncol Rep. 2018;40:3603-3610.
    PubMed     Abstract available


    November 2018
  108. FUDHAILI A, Yoon NA, Kang S, Ryu J, et al
    Resveratrol epigenetically regulates the expression of zinc finger protein 36 in nonsmall cell lung cancer cell lines.
    Oncol Rep. 2018 Nov 30. doi: 10.3892/or.2018.6898.
    PubMed     Abstract available


  109. AO X, Jiang M, Zhou J, Liang H, et al
    lincRNAp21 inhibits the progression of nonsmall cell lung cancer via targeting miR175p.
    Oncol Rep. 2018 Nov 30. doi: 10.3892/or.2018.6900.
    PubMed     Abstract available


  110. XU L, Du H, Zhang Q, Wang C, et al
    BAI1associated protein 2like 2 is a potential biomarker in lung cancer.
    Oncol Rep. 2018 Nov 26. doi: 10.3892/or.2018.6883.
    PubMed     Abstract available


  111. XU H, Jiao X, Wu Y, Li S, et al
    Exosomes derived from PM2.5treated lung cancer cells promote the growth of lung cancer via the Wnt3a/betacatenin pathway.
    Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6862.
    PubMed     Abstract available


  112. LAI YH, Liu HY, Huang CY, Chau YP, et al
    MitochondrialDNAassociated TLR9 signalling is a potential serological biomarker for nonsmall cell lung cancer.
    Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6855.
    PubMed     Abstract available


  113. MOHAMMED A, Zhang C, Zhang S, Shen Q, et al
    Inhibition of cell proliferation and migration in nonsmall cell lung cancer cells through the suppression of LYPLA1.
    Oncol Rep. 2018 Nov 9. doi: 10.3892/or.2018.6857.
    PubMed     Abstract available


  114. LIU H, Peng J, Zhao M, Ma P, et al
    Downregulation of DLL4 predicts poor survival in nonsmall cell lung cancer patients due to promotion of lymph node metastasis.
    Oncol Rep. 2018;40:2988-2996.
    PubMed     Abstract available


  115. LI B, Ding CM, Li YX, Peng JC, et al
    MicroRNA145 inhibits migration and induces apoptosis in human nonsmall cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
    Oncol Rep. 2018;40:2944-2954.
    PubMed     Abstract available


  116. XIANG R, Cui Y, Wang Y, Xie T, et al
    Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis.
    Oncol Rep. 2018;40:3040-3048.
    PubMed     Abstract available


  117. LI J, Wang J, Yu J, Zhao Y, et al
    Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro.
    Oncol Rep. 2018;40:2477-2486.
    PubMed     Abstract available


  118. LV W, Yu X, Li W, Feng N, et al
    Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
    Oncol Rep. 2018;40:2698-2709.
    PubMed     Abstract available


  119. LIU J, Wang D, Meng X, Sun X, et al
    18Falfatide positron emission tomography may predict antiangiogenic responses.
    Oncol Rep. 2018;40:2896-2905.
    PubMed     Abstract available


  120. KAOWINN S, Kaewpiboon C, Koh SS, Kramer OH, et al
    STAT1HDAC4 signaling induces epithelialmesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2.
    Oncol Rep. 2018;40:2619-2627.
    PubMed     Abstract available


    October 2018
  121. ZHOU H, Chen A, Shen J, Zhang X, et al
    Long non-coding RNA LOC285194 functions as a tumor suppressor by targeting p53 in non-small cell lung cancer.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6839.
    PubMed     Abstract available


  122. CHOI YJ, Kim JH, Rho JK, Kim JS, et al
    [Corrigendum] AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Oncol Rep. 2018 Oct 29. doi: 10.3892/or.2018.6831.
    PubMed     Abstract available


  123. OTANI T, Kondo K, Takizawa H, Kajiura K, et al
    Noninvasive monitoring of cisplatin and erlotinib efficacy against lung cancer in orthotopic SCID mouse models by small animal FDGPET/CT and CT.
    Oncol Rep. 2018 Oct 24. doi: 10.3892/or.2018.6818.
    PubMed     Abstract available


  124. PARK SE, Kim DE, Kim MJ, Lee JS, et al
    Vorinostat enhances gefitinibinduced cell death through reactive oxygen speciesdependent cleavage of HSP90 and its clients in nonsmall cell lung cancer with the EGFR mutation.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6814.
    PubMed     Abstract available


  125. MUN JG, Kee JY, Han YH, Lee S, et al
    Galla Rhois water extract inhibits lung metastasis by inducing AMPKmediated apoptosis and suppressing metastatic properties of colorectal cancer cells.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6812.
    PubMed     Abstract available


  126. WANG N, Wang L, Meng X, Wang J, et al
    Osimertinib (AZD9291) increases radiosensitivity in EGFR T790M nonsmall cell lung cancer.
    Oncol Rep. 2018 Oct 17. doi: 10.3892/or.2018.6803.
    PubMed     Abstract available


  127. ZHAO Y, Chen S, Shen F, Long D, et al
    In vitro neutralization of autocrine IL10 affects Op18/stathmin signaling in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 Oct 15. doi: 10.3892/or.2018.6795.
    PubMed     Abstract available


  128. HUANG F, Wu Y, Tan H, Guo T, et al
    Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Oncol Rep. 2018 Oct 12. doi: 10.3892/or.2018.6787.
    PubMed     Abstract available


  129. YIN Y, Liu H, Xu J, Shi D, et al
    miR1443p regulates the resistance of lung cancer to cisplatin by targeting Nrf2.
    Oncol Rep. 2018 Oct 8. doi: 10.3892/or.2018.6772.
    PubMed     Abstract available


  130. LEI Y, Guo W, Chen B, Chen L, et al
    Tumorreleased lncRNA H19 promotes gefitinib resistance via packaging into exosomes in nonsmall cell lung cancer.
    Oncol Rep. 2018 Oct 3. doi: 10.3892/or.2018.6762.
    PubMed     Abstract available


  131. XU F, Gao X, Pan H
    Pectolinarigenin inhibits nonsmall cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway.
    Oncol Rep. 2018 Oct 2. doi: 10.3892/or.2018.6759.
    PubMed     Abstract available


  132. GAO J, Qiu X, Xi G, Liu H, et al
    Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in nonsmall cell lung cancer.
    Oncol Rep. 2018;40:1971-1984.
    PubMed     Abstract available


  133. LI TT, He RQ, Ma J, Li ZY, et al
    Long noncoding RNAs in small cell lung cancer: A potential opening to combat the disease (Review).
    Oncol Rep. 2018;40:1831-1842.
    PubMed     Abstract available


  134. ZHANG G, Fang T, Chang M, Li J, et al
    Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling.
    Oncol Rep. 2018;40:1937-1946.
    PubMed     Abstract available


  135. XIA A, Li H, Li R, Lu L, et al
    Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Oncol Rep. 2018;40:2353-2362.
    PubMed     Abstract available


  136. ZHAO W, Hu JX, Hao RM, Zhang Q, et al
    Induction of microRNAlet7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1.
    Oncol Rep. 2018;40:1843-1854.
    PubMed     Abstract available


  137. LAM SK, U KP, Li YY, Xu S, et al
    Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models.
    Oncol Rep. 2018;40:1994-2004.
    PubMed     Abstract available


    September 2018
  138. CHEN M, Hu C, Guo Y, Jiang R, et al
    Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Oncol Rep. 2018;40:1339-1347.
    PubMed     Abstract available


  139. LOU Z, Lee BS, Ha T, Xu Y, et al
    ESE1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo.
    Oncol Rep. 2018;40:1734-1742.
    PubMed     Abstract available


  140. ONODERA K, Sakurada A, Notsuda H, Watanabe T, et al
    Growth inhibition of KRAS and EGFRmutant lung adenocarcinoma by cosuppression of STAT3 and the SRC/ARHGAP35 axis.
    Oncol Rep. 2018;40:1761-1768.
    PubMed     Abstract available


    August 2018
  141. LIU KT, Yeh IJ, Chou SK, Yen MC, et al
    Regulatory mechanism of fatty acidCoA metabolic enzymes under endoplasmic reticulum stress in lung cancer.
    Oncol Rep. 2018 Aug 21. doi: 10.3892/or.2018.6664.
    PubMed     Abstract available


  142. HU P, Wong PT, Zhou Q, Sheng L, et al
    Clinical relevance of the multidrug resistanceassociated protein 1 gene in nonsmall cell lung cancer: A systematic review and metaanalysis.
    Oncol Rep. 2018 Aug 17. doi: 10.3892/or.2018.6652.
    PubMed     Abstract available


  143. ZHANG J, Wen G, Sun L, Yuan W, et al
    Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6638.
    PubMed     Abstract available


  144. ZHU S, Zhang L, Zhao Z, Fu W, et al
    MicroRNA92a3p inhibits the cell proliferation, migration and invasion of Wilms tumor by targeting NOTCH1.
    Oncol Rep. 2018;40:571-578.
    PubMed     Abstract available


  145. FENG L, Yang Y, Li M, Song J, et al
    Systems biology analysis of the lung cancerrelated secretome.
    Oncol Rep. 2018;40:1103-1118.
    PubMed     Abstract available


    July 2018
  146. ZHONG L, Sun S, Yao S, Han X, et al
    Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6591.
    PubMed     Abstract available


  147. HUANG C, Yang M, Deng J, Li P, et al
    Upregulation and activation of p53 by erastininduced reactive oxygen species contribute to cytotoxic and cytostatic effects in A549 lung cancer cells.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6585.
    PubMed     Abstract available


  148. WANG Y, He J, Jiang H, Zhang Q, et al
    Nicotine enhances storeoperated calcium entry by upregulating HIF1alpha and SOCC components in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6580.
    PubMed     Abstract available


  149. GONG Q, Cao X, Cao J, Yang X, et al
    Casticin suppresses the carcinogenesis of small cell lung cancer H446 cells through activation of AMPK/FoxO3a signaling.
    Oncol Rep. 2018 Jul 5. doi: 10.3892/or.2018.6547.
    PubMed     Abstract available


  150. ISOBE K, Kakimoto A, Mikami T, Kaburaki K, et al
    PD-L1 mRNA expression in EGFR-mutant lung adenocarcinoma.
    Oncol Rep. 2018;40:331-338.
    PubMed     Abstract available


  151. YIN XL, Lv Y, Wang S, Zhang YQ, et al
    Morusin suppresses A549 cell migration and induces cell apoptosis by downregulating the expression of COX2 and VEGF genes.
    Oncol Rep. 2018;40:504-510.
    PubMed     Abstract available


  152. UCHIDA D, Kuribayashi N, Kinouchi M, Sawatani Y, et al
    Effect of a novel orally bioavailable CXCR4 inhibitor, AMD070, on the metastasis of oral cancer cells.
    Oncol Rep. 2018;40:303-308.
    PubMed     Abstract available


  153. HU BD, Guo J, Ye YZ, Du T, et al
    Specific inhibitor of Notch3 enhances the sensitivity of NSCLC cells to gemcitabine.
    Oncol Rep. 2018;40:155-164.
    PubMed     Abstract available


  154. ZHANG W, Cui Q, Qu W, Ding X, et al
    TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
    Oncol Rep. 2018;40:206-216.
    PubMed     Abstract available


  155. HE RQ, Gao L, Ma J, Li ZY, et al
    Oncogenic role of miR1835p in lung adenocarcinoma: A comprehensive study of qPCR, in vitro experiments and bioinformatic analysis.
    Oncol Rep. 2018;40:83-100.
    PubMed     Abstract available


    June 2018
  156. PARK WH
    Hydrogen peroxide inhibits the growth of lung cancer cells via the induction of cell death and G1phase arrest.
    Oncol Rep. 2018 Jun 28. doi: 10.3892/or.2018.6535.
    PubMed     Abstract available


  157. GU Y, Zhang M
    Upregulation of the Kank1 gene inhibits human lung cancer progression in vitro and in vivo.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6526.
    PubMed     Abstract available


  158. CUI E, Guo H, Shen M, Yu H, et al
    Adiponectin inhibits migration and invasion by reversing epithelialmesenchymal transition in nonsmall cell lung carcinoma.
    Oncol Rep. 2018 Jun 25. doi: 10.3892/or.2018.6523.
    PubMed     Abstract available


  159. ZHANG L, Qi Y, Xing K, Qian S, et al
    A novel strategy of EGFRTKI combined chemotherapy in the treatment of human lung cancer with EGFRsensitive mutation.
    Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6499.
    PubMed     Abstract available


  160. JIANG K, Shen M, Chen Y, Xu W, et al
    miR150 promotes the proliferation and migration of nonsmall cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6487.
    PubMed     Abstract available


  161. JIN D, Wu Y, Shao C, Gao Y, et al
    Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human nonsmall lung cancer cells by regulating the YAP pathway.
    Oncol Rep. 2018 Jun 12. doi: 10.3892/or.2018.6486.
    PubMed     Abstract available


  162. LI F, Zhu T, Yue Y, Zhu X, et al
    Preliminary mechanisms of regulating PDL1 expression in nonsmall cell lung cancer during the EMT process.
    Oncol Rep. 2018 Jun 5. doi: 10.3892/or.2018.6474.
    PubMed     Abstract available


  163. JI Y, Jiang J, Huang L, Feng W, et al
    Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.
    Oncol Rep. 2018 Jun 4. doi: 10.3892/or.2018.6473.
    PubMed     Abstract available


  164. ZHANG Y, He S, Mei R, Kang Y, et al
    miR29a suppresses IL13induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells.
    Oncol Rep. 2018;39:2613-2623.
    PubMed     Abstract available


  165. YANG J, Li L, Xu C, Yang D, et al
    CT1042, a novel anticancer agent, exhibits effects by activating p53 and inhibiting survivin.
    Oncol Rep. 2018;39:2759-2768.
    PubMed     Abstract available


  166. MA Y, Yan Z, Deng X, Guo J, et al
    Anticancer effect of exogenous hydrogen sulfide in cisplatinresistant A549/DDP cells.
    Oncol Rep. 2018;39:2969-2977.
    PubMed     Abstract available


    May 2018
  167. SATAR NA, Fakiruddin KS, Lim MN, Mok PL, et al
    Novel triplepositive markers identified in human nonsmall cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6461.
    PubMed     Abstract available


  168. XU G, Du J, Wang F, Zhang F, et al
    RAD52 motifcontaining protein 1 promotes nonsmall cell lung cancer cell proliferation and survival via cell cycle regulation.
    Oncol Rep. 2018 May 23. doi: 10.3892/or.2018.6459.
    PubMed     Abstract available


  169. CHEN T, Li B, Xu Y, Meng S, et al
    Luteolin reduces cancerinduced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6453.
    PubMed     Abstract available


  170. WAN J, Ling X, Peng B, Ding G, et al
    miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6439.
    PubMed     Abstract available


  171. LIN C, Qin Y, Zhang H, Gao MY, et al
    EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in nonsmall cell lung cancer cells.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6417.
    PubMed     Abstract available


  172. WANG M, Liu Y, Qian X, Wei N, et al
    Downregulation of occludin affects the proliferation, apoptosis and metastatic properties of human lung carcinoma.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6408.
    PubMed     Abstract available


  173. PAN Y, Wang H, Ma D, Ji Z, et al
    miR24 may be a negative regulator of menin in lung cancer.
    Oncol Rep. 2018;39:2342-2350.
    PubMed     Abstract available


  174. XU S, Yang F, Liu R, Li X, et al
    Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis.
    Oncol Rep. 2018;39:2376-2384.
    PubMed     Abstract available


  175. LI Y, Wei Y, Yuan W, Huang Q, et al
    DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
    Oncol Rep. 2018;39:2071-2080.
    PubMed     Abstract available


    April 2018
  176. DING J, Jia X, Zuo B, He J, et al
    A novel monoclonal antibody targeting a novel epitope of VEcadherin inhibits vasculogenic mimicry of lung cancer cells.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6374.
    PubMed     Abstract available


  177. LIU L, Han C, Yu H, Zhu W, et al
    Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrialmediated apoptosis.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6363.
    PubMed     Abstract available


  178. CHEN Z, Zhu J, Zhu Y, Wang J, et al
    MicroRNA-616 promotes the progression of ovarian cancer by targeting TIMP2.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6368.
    PubMed     Abstract available


  179. OH YJ, Park SY, Seo YH
    The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
    Oncol Rep. 2018;39:1775-1782.
    PubMed     Abstract available


  180. ZHOU J, Hu Q, Zhang X, Zheng J, et al
    Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.
    Oncol Rep. 2018;39:1783-1792.
    PubMed     Abstract available


    March 2018
  181. MA Y, Wu X, Xiu Z, Liu X, et al
    Cytochalasin H isolated from mangrovederived endophytic fungus induces apoptosis and inhibits migration in lung cancer cells.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6347.
    PubMed     Abstract available


  182. PARK BR, Lee SA, Moon SM, Kim CS, et al
    Anthricininduced caspasedependent apoptosis through IGF1R/PI3K/AKT pathway inhibition in A549 human nonsmall lung cancer cells.
    Oncol Rep. 2018 Mar 27. doi: 10.3892/or.2018.6333.
    PubMed     Abstract available


  183. LIU M, Liu H, Chen J
    Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review).
    Oncol Rep. 2018;39:901-911.
    PubMed     Abstract available


  184. HE X, Zhang C, Shi C, Lu Q, et al
    Meta-analysis of mRNA expression profiles to identify differentially expressed genes in lung adenocarcinoma tissue from smokers and non-smokers.
    Oncol Rep. 2018;39:929-938.
    PubMed     Abstract available


  185. ISHIWATA T, Iwasawa S, Ebata T, Fan M, et al
    Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lung.
    Oncol Rep. 2018;39:1148-1154.
    PubMed     Abstract available


    February 2018
  186. WANG Q, Chen Y, Feng H, Zhang B, et al
    Prognostic and predictive value of HURP in nonsmall cell lung cancer.
    Oncol Rep. 2018 Feb 26. doi: 10.3892/or.2018.6280.
    PubMed     Abstract available


  187. BAEK JH, Yim JH, Song JY, Um HD, et al
    Knockdown of end-binding protein 1 induces apoptosis in radioresistant A549 lung cancer cells via p38 kinase-dependent COX-2 upregulation.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6278.
    PubMed     Abstract available


  188. TIAN H, Yin L, Ding K, Xia YY, et al
    Raf1 is a prognostic factor for progression in patients with nonsmall cell lung cancer after radiotherapy.
    Oncol Rep. 2018 Feb 22. doi: 10.3892/or.2018.6277.
    PubMed     Abstract available


  189. LIU J, Xing Y, Rong L
    miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Oncol Rep. 2018 Feb 13. doi: 10.3892/or.2018.6268.
    PubMed     Abstract available


  190. KEERATICHAMROEN S, Lirdprapamongkol K, Svasti J
    Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6258.
    PubMed     Abstract available


  191. CHANG WA, Yen MC, Hung JY, Yang CJ, et al
    Investigation of the role of tumor necrosis factor-like weak inducer of apoptosis in non-small cell lung cancer.
    Oncol Rep. 2018;39:573-581.
    PubMed     Abstract available


  192. HUANG F, Chen J, Wang Z, Lan R, et al
    delta-Catenin promotes tumorigenesis and metastasis of lung adenocarcinoma.
    Oncol Rep. 2018;39:809-817.
    PubMed     Abstract available


    January 2018
  193. HU Y, Li X, Lin L, Liang S, et al
    Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6234.
    PubMed     Abstract available


  194. SEO YS, Kang OH, Kong R, Zhou T, et al
    Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 23. doi: 10.3892/or.2018.6230.
    PubMed     Abstract available


  195. LI B, Ding CM, Li YX, Peng JC, et al
    Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Oncol Rep. 2018 Jan 15. doi: 10.3892/or.2018.6215.
    PubMed     Abstract available


  196. KANAJI N, Kamitori K, Hossain A, Noguchi C, et al
    Additive antitumour effect of Dallose in combination with cisplatin in non-small cell lung cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6192.
    PubMed     Abstract available


  197. LIU F, Gao S, Yang Y, Zhao X, et al
    Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6188.
    PubMed     Abstract available


  198. FU S, Liu C, Huang Q, Fan S, et al
    Estrogen receptor beta1 activation accelerates resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6186.
    PubMed     Abstract available


  199. TANG Z, Shen Q, Xie H, Zhou Z, et al
    Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and gamma-ray irradiation was elucidated.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6181.
    PubMed     Abstract available


  200. OLBROMSKI M, Rzechonek A, Grzegrzolka J, Glatzel-Plucinska N, et al
    Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma.
    Oncol Rep. 2018;39:201-208.
    PubMed     Abstract available


    December 2017
  201. ZHAO L, Liu L, Dong Z, Xiong J, et al
    miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
    Oncol Rep. 2017;38:3522-3530.
    PubMed     Abstract available


    November 2017
  202. TANG C, Luo H, Luo D, Yang H, et al
    Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6109.
    PubMed     Abstract available


  203. LI Y, Hu T, Chen T, Yang T, et al
    Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6111.
    PubMed     Abstract available


  204. PARK WH
    MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6107.
    PubMed     Abstract available


  205. ZHANG C, Xiao X, Chen M, Aldharee H, et al
    Liver kinase B1 restoration promotes exosome secretion and motility of lung cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6085.
    PubMed     Abstract available


  206. JIMENEZ-HERNANDEZ LE, Vazquez-Santillan K, Castro-Oropeza R, Martinez-Ruiz G, et al
    NRP1-positive lung cancer cells possess tumor-initiating properties.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6089.
    PubMed     Abstract available


  207. YANG L, Zha TQ, He X, Chen L, et al
    Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6086.
    PubMed     Abstract available


  208. WANG H, Zhang Y, Wu Q, Wang YB, et al
    miR-16 mimics inhibit TGF-beta1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6088.
    PubMed     Abstract available


    October 2017
  209. NI X, Cao X, Wu Y, Wu J, et al
    FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Oncol Rep. 2017 Oct 31. doi: 10.3892/or.2017.6061.
    PubMed     Abstract available


  210. XU Z, Xu J, Lu H, Lin B, et al
    LARP1 is regulated by the XIST/miR-374a axis and functions as an oncogene in non-small cell lung carcinoma.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6040.
    PubMed     Abstract available


  211. ZHANG C, Yu P, Zhu L, Zhao Q, et al
    Blockade of alpha7 nicotinic acetylcholine receptors inhibit nicotine-induced tumor growth and vimentin expression in non-small cell lung cancer through MEK/ERK signaling way.
    Oncol Rep. 2017 Oct 2. doi: 10.3892/or.2017.6014.
    PubMed     Abstract available


    September 2017
  212. QIU X, Guan X, Liu W, Zhang Y, et al
    DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6000.
    PubMed     Abstract available


  213. XU M, Tang X, Guo J, Sun W, et al
    Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6002.
    PubMed     Abstract available


  214. WANG RH, Cao HM, Tian ZJ, Jin B, et al
    [Retracted] Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6006.
    PubMed     Abstract available


  215. WEI Y, Li D, Wang D, Qiu T, et al
    Evaluation of microRNA-203 in bone metastasis of patients with non-small cell lung cancer through TGF-beta/SMAD2 expression.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5987.
    PubMed     Abstract available


  216. TIAN C, Li J, Ren L, Peng R, et al
    MicroRNA-381 serves as a prognostic factor and inhibits migration and invasion in non-small cell lung cancer by targeting LRH-1.
    Oncol Rep. 2017 Sep 14. doi: 10.3892/or.2017.5956.
    PubMed     Abstract available


  217. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Abstract available


  218. HAN Z, Zhou X, Li S, Qin Y, et al
    Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5938.
    PubMed     Abstract available


    August 2017
  219. KONG R, Liu W, Guo Y, Feng J, et al
    Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Oncol Rep. 2017 Aug 28. doi: 10.3892/or.2017.5927.
    PubMed     Abstract available


  220. FUNAKI S, Shintani Y, Kawamura T, Kanzaki R, et al
    Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-beta induced epithelial mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5894.
    PubMed     Abstract available


  221. TANG T, Huan L, Zhang S, Zhou H, et al
    MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5885.
    PubMed     Abstract available


    July 2017
  222. WANG D, Cao Q, Qu M, Xiao Z, et al
    MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.
    Oncol Rep. 2017 Jul 28. doi: 10.3892/or.2017.5854.
    PubMed     Abstract available


  223. ZHOU F, Nie L, Feng D, Guo S, et al
    MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF1R-mediated AKT and ERK pathways.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5835.
    PubMed     Abstract available


  224. WANG Y, Zhao M, Liu J, Sun Z, et al
    miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3beta signaling pathway.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5808.
    PubMed     Abstract available


  225. HONG CF, Chen WY, Wu CW
    Upregulation of Wnt signaling under hypoxia promotes lung cancer progression.
    Oncol Rep. 2017 Jul 12. doi: 10.3892/or.2017.5807.
    PubMed     Abstract available


    June 2017
  226. KIM GT, Kim SY, Kim YM
    Torilis japonica extract fraction compound, EGFR-targeted inhibition of cancer abnormal metastasis in A549 lung cancer cells.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5771.
    PubMed     Abstract available


  227. ZHANG Z, Rui W, Wang ZC, Liu DX, et al
    Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5760.
    PubMed     Abstract available


  228. TANG Y, He R, An J, Deng P, et al
    lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP.
    Oncol Rep. 2017 Jun 26. doi: 10.3892/or.2017.5751.
    PubMed     Abstract available


  229. XU Z, Yan Y, Zeng S, Qian L, et al
    Reducing autophagy and inducing G1 phase arrest by aloperine enhances radio-sensitivity in lung cancer cells.
    Oncol Rep. 2017 Jun 19. doi: 10.3892/or.2017.5732.
    PubMed     Abstract available


  230. ZENG Y, Zhu J, Qin H, Shen D, et al
    Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5690.
    PubMed     Abstract available


  231. XU W, Wu B, Fu L, Chen J, et al
    Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Oncol Rep. 2017;37:3219-3226.
    PubMed     Abstract available


  232. SEIKE M, Kim CH, Zou F, Noro R, et al
    AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Oncol Rep. 2017;37:3261-3269.
    PubMed     Abstract available


    May 2017
  233. SCHLUCKEBIER L, Aran V, De Moraes J, Paiva H, et al
    XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5680.
    PubMed     Abstract available


  234. LIU L, Xiao L, Liang X, Chen L, et al
    TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5638.
    PubMed     Abstract available


  235. TANG F, Hu P, Yang Z, Xue C, et al
    SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
    Oncol Rep. 2017 May 10. doi: 10.3892/or.2017.5635.
    PubMed     Abstract available


  236. LI GJ, Zhao GQ, Yang JP, Zhou YC, et al
    Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5624.
    PubMed     Abstract available


  237. YE Z, Fang B, Pan J, Zhang N, et al
    miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Oncol Rep. 2017 May 3. doi: 10.3892/or.2017.5619.
    PubMed     Abstract available


  238. YAN J, Ma C, Gao Y
    MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.
    Oncol Rep. 2017;37:3146-3154.
    PubMed     Abstract available


  239. WANG J, Wang Y, Sun D, Ren F, et al
    CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017;37:3068-3074.
    PubMed     Abstract available


  240. CHEN G, Yu H, Satherley L, Zabkiewicz C, et al
    The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.
    Oncol Rep. 2017;37:2695-2701.
    PubMed     Abstract available


  241. CAI Y, Ruan J, Yao X, Zhao L, et al
    MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
    Oncol Rep. 2017;37:2787-2794.
    PubMed     Abstract available


  242. SUZAWA K, Yamamoto H, Ohashi K, Hashida S, et al
    Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Oncol Rep. 2017;37:3100-3106.
    PubMed     Abstract available


  243. WANG X, Li M, Hu M, Wei P, et al
    BAMBI overexpression together with beta-sitosterol ameliorates NSCLC via inhibiting autophagy and inactivating TGF-beta/Smad2/3 pathway.
    Oncol Rep. 2017;37:3046-3054.
    PubMed     Abstract available


    April 2017
  244. ZHANG Y, Sui J, Shen X, Li C, et al
    Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5612.
    PubMed     Abstract available


  245. WANG H, Zhan Y, Jin J, Zhang C, et al
    MicroRNA-15b promotes proliferation and invasion of nonsmall cell lung carcinoma cells by directly targeting TIMP2.
    Oncol Rep. 2017 Apr 26. doi: 10.3892/or.2017.5604.
    PubMed     Abstract available


  246. YOO HS, Kim JM, Jo E, Cho CK, et al
    Modified Panax ginseng extract regulates autophagy by AMPK signaling in A549 human lung cancer cells.
    Oncol Rep. 2017 Apr 20. doi: 10.3892/or.2017.5590.
    PubMed     Abstract available


  247. WANG W, Zhang L, Liu L, Zheng Y, et al
    Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance.
    Oncol Rep. 2017;37:1989-1997.
    PubMed     Abstract available


  248. SHEN F, Long D, Yu T, Chen X, et al
    Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Oncol Rep. 2017;37:2481-2489.
    PubMed     Abstract available


  249. ZHANG R, Gu J, Chen J, Ni J, et al
    High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Oncol Rep. 2017;37:2137-2146.
    PubMed     Abstract available


  250. CHENG R, Lu C, Zhang G, Zhang G, et al
    Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.
    Oncol Rep. 2017;37:2129-2136.
    PubMed     Abstract available


    March 2017
  251. ZHANG L, Xiao X, An H, Wang J, et al
    Inhibition of CCR7 promotes NF-kappaB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5524.
    PubMed     Abstract available


  252. XIANG GL, Zhu XH, Lin CZ, Wang LJ, et al
    125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1alpha and VEGF expression in lung carcinoma xenografts.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5521.
    PubMed     Abstract available


  253. YANG N, Liang Y, Yang P, Ji F, et al
    Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 17. doi: 10.3892/or.2017.5514.
    PubMed     Abstract available


  254. YANG JS, Lin CA, Lu CC, Wen YF, et al
    Carboxamide analog ITR-284 evokes apoptosis and inhibits migration ability in human lung adenocarcinoma A549 cells.
    Oncol Rep. 2017;37:1786-1792.
    PubMed     Abstract available


  255. TIETJE A, Yang X, Yu X, Wei Y, et al
    MICA/IL-12: A novel bifunctional protein for killer cell activation.
    Oncol Rep. 2017;37:1889-1895.
    PubMed     Abstract available


    February 2017
  256. KAKE S, Usui T, Ohama T, Yamawaki H, et al
    Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Oncol Rep. 2017;37:1100-1106.
    PubMed     Abstract available


  257. CHEN T, Gong W, Tian H, Wang H, et al
    Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.
    Oncol Rep. 2017;37:1235-1242.
    PubMed     Abstract available


  258. KIM MH, Jeong YJ, Cho HJ, Hoe HS, et al
    Delphinidin inhibits angiogenesis through the suppression of HIF-1alpha and VEGF expression in A549 lung cancer cells.
    Oncol Rep. 2017;37:777-784.
    PubMed     Abstract available


  259. ZHANG B, Zhang Y, Yu D
    Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Oncol Rep. 2017;37:937-944.
    PubMed     Abstract available


  260. LIN D, Kuang G, Wan J, Zhang X, et al
    Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression.
    Oncol Rep. 2017;37:895-902.
    PubMed     Abstract available


    December 2016
  261. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Abstract available


  262. WEN R, Xiao Y, Zhang Y, Yang M, et al
    Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Oncol Rep. 2016;36:3172-3180.
    PubMed     Abstract available


  263. LU X, Guo H, Chen X, Xiao J, et al
    Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-beta1 in lung adenocarcinoma cells.
    Oncol Rep. 2016;36:3105-3112.
    PubMed     Abstract available


    October 2016
  264. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: